Product Detail
5-Methyluracil-d8
. Stable Isotope Reagent
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotope Reagent
API Family
.
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
5-Methyluracil-d8 Product Information
5-Methyluracil-d8 is listed under Stable Isotope Reagent. It is associated with . and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103737.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
5-Methyluracil-d8
CAS No.
2376506-60-2
CAT No.
CS-T-103737
Molecular Formula
C₁₀H₆D₈N₂O₆
Molecular Weight
266.28
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
O=C(NC1=O)N([C@H]2[C@@](O)([2H])[C@@](O)([2H])[C@@H](C([2H])([2H])O)O2)C([2H])=C1C([2H])([2H])[2H]
IUPAC Name
Ribothymidine-d8
Hazard Compound
Refer MSDS for complete information.
Description
Overview
5-Methyluracil-d8 is an isotopically labelled analog of 5-Methyluracil (M338190), a pyrimidine nucleoside referred to as m5U. It has been studied as a primary degradation product of tRNA and an urinary nucleoside used as a biological marker for patients with colorectal cancer.
Synonyms
Ribothymidine-d8
Application Notes
5-Methyluracil-d8 is an isotopically labelled analog of 5-Methyluracil (M338190), a pyrimidine nucleoside referred to as m5U. It has been studied as a primary degradation product of tRNA and an urinary nucleoside used as a biological marker for patients with colorectal cancer.
References
Taniguchi, Y., et. al.: Tetrahedron Lett., (2019);Hussain, S.: Methods, 156, 60 (2019);Borek, E., et al.: Cancer Res., 37, 3362 (1977);Sander, G., et al.: Clin. Sci.,71, 367 (1986); Sander, G., et al.: Ann. Nutr. Metab., 30, 137 (1986);Rasmuson, T., et al.: Acta Oncol., 34, 61 (1995),